Ilaris (canakinumab) is a brand-name injectable drug prescribed for conditions including Still’s disease and periodic fever syndromes in adults and some children. As with other drugs, Ilaris can cause ...

Ilaris (canakinumab) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat certain periodic fever conditions and certain types of Still’s disease.

Ilaris (canakinumab) can cause side effects that range from mild to serious. More common side effects include weight gain and the common cold. If side effects from Ilaris become difficult to tolerate, ...

Ilaris is now approved for the treatment of active systemic juvenile idiopathic arthritis (:SJIA) in patients AGED 2 years and above in the US. The approval was based on encouraging data from two ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy ...

Novartis has been laboring for the last few years to expand the market for Ilaris, a drug that’s currently approved to treat a few rare inflammatory diseases, but those efforts have turned in mixed ...

Novartis is celebrating after getting the green light for Ilaris from European regulators for patients suffering from gouty arthritis. Novartis is celebrating after getting the green light for Ilaris ...

Credit: Getty Images. Ilaris is an interleukin-1β blocker. The Food and Drug Administration (FDA) has approved Ilaris ® (canakinumab) for the symptomatic treatment of adult patients with gout flares ...

The FDA quietly approved the interleukin (IL)-1 inhibitor canakinumab (Ilaris) for gout 10 days ago, with no announcement from either the agency or the drug's manufacturer, Novartis -- leaving ...

Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Ilaris - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. "Ilaris- Drug Insight and Market Forecast - ...

The prescribed dosage for Ilaris (canakinumab) may depend on your individual treatment plan. Factors like your medical history and body weight may affect your dosage of Ilaris. Ilaris (canakinumab) is ...